APA Alıntı

Li, Y., Zhou, Y., Mao, F., Shen, S., Zhao, B., Xu, Y., . . . Sun, Q. (2020). miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1. Front Oncol.

Chicago Stili Alıntı

Li, Yan, et al. "MiR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1." Front Oncol 2020.

MLA Alıntı

Li, Yan, et al. "MiR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1." Front Oncol 2020.